$ACER Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Acer Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Acer Therapeutics Inc.. Get notifications about new insider transactions in Acer Therapeutics Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 30 2008 | OPXA | Opexa Therapeutics ... | Randall Lorin | Director | Option Exercise | A | 1.17 | 10,000 | 11,700 | 30,000 | |
Jun 30 2008 | OPXA | Opexa Therapeutics ... | Hung David | Director | Option Exercise | A | 1.17 | 10,000 | 11,700 | 55,000 | |
Jun 30 2008 | OPXA | Opexa Therapeutics ... | Bailey Gregory | Director | Option Exercise | A | 1.17 | 10,000 | 11,700 | 103,928 | |
May 08 2008 | OPXA | Opexa Therapeutics ... | Rill Donna R | Vice President, Ope ... | Option Exercise | A | 1.09 | 3,000 | 3,270 | 70,380 | |
May 08 2008 | OPXA | Opexa Therapeutics ... | Hohlfeld Lynne | CFO | Option Exercise | A | 1.09 | 8,000 | 8,720 | 75,000 | |
May 08 2008 | OPXA | Opexa Therapeutics ... | Williams Jimmy Calvin | Chief Operating Off ... | Option Exercise | A | 1.09 | 10,300 | 11,227 | 110,930 | |
May 08 2008 | OPXA | Opexa Therapeutics ... | McWilliams David | CEO | Option Exercise | A | 1.09 | 8,700 | 9,483 | 218,668 | |
May 07 2008 | OPXA | Opexa Therapeutics ... | Richman Michael | Director | Option Exercise | A | 1.09 | 11,400 | 12,426 | 56,400 | |
May 07 2008 | OPXA | Opexa Therapeutics ... | Hung David | Director | Grant | A | 1.09 | 31,900 | 34,771 | 31,900 | 0 to 31.9 K |
May 07 2008 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Option Exercise | A | 1.09 | 11,900 | 12,971 | 79,734 | |
May 07 2008 | OPXA | Opexa Therapeutics ... | Bailey Gregory | Director | Grant | A | 1.09 | 31,000 | 33,790 | 131,000 | 100 K to 131 K (+31.00 %) |
Apr 18 2008 | OPXA | Opexa Therapeutics ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 1.30 | 5,499 | 7,168 | 772,848 | 778.3 K to 772.8 K (-0.71 %) |
Apr 09 2008 | OPXA | Opexa Therapeutics ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 1.40 | 100 | 140 | 778,347 | 778.4 K to 778.3 K (-0.01 %) |
Feb 25 2008 | OPXA | Opexa Therapeutics ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 1.75 | 399 | 698 | 778,447 | 778.8 K to 778.4 K (-0.05 %) |
Feb 25 2008 | OPXA | Opexa Therapeutics ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 1.75 | 114 | 200 | 778,846 | 779 K to 778.8 K (-0.01 %) |
Feb 22 2008 | OPXA | Opexa Therapeutics ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 1.71 | 17,786 | 30,403 | 778,960 | 796.7 K to 779 K (-2.23 %) |
Feb 19 2008 | OPXA | Opexa Therapeutics ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 1.75 | 118,830 | 208,297 | 777,202 | 896 K to 777.2 K (-13.26 %) |
Feb 19 2008 | OPXA | Opexa Therapeutics ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 1.81 | 68,951 | 124,505 | 896,032 | 965 K to 896 K (-7.15 %) |
Feb 19 2008 | OPXA | Opexa Therapeutics ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 1.80 | 19,544 | 35,179 | 964,983 | 984.5 K to 965 K (-1.99 %) |
Feb 19 2008 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Option Exercise | P | 2.00 | 10,000 | 20,000 | 67,834 | |
Feb 19 2008 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Buy | P | 2.00 | 10,000 | 20,000 | 28,550 | 18.6 K to 28.6 K (+53.91 %) |
Jun 21 2007 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Option Exercise | A | 5.47 | 10,000 | 54,700 | 45,000 | |
Jun 21 2007 | OPXA | Opexa Therapeutics ... | Bailey Gregory | Director | Option Exercise | A | 5.47 | 10,000 | 54,700 | 45,000 | |
Jun 21 2007 | OPXA | Opexa Therapeutics ... | Hung David | Director | Option Exercise | A | 5.47 | 10,000 | 54,700 | 45,000 | |
Jun 19 2007 | OPXA | Opexa Therapeutics ... | Richman Michael | Director | Option Exercise | A | 5.47 | 10,000 | 54,700 | 45,000 | |
Jun 19 2007 | OPXA | Opexa Therapeutics ... | Rill Donna R | Vice President of O ... | Option Exercise | A | 5.47 | 32,000 | 175,040 | 67,380 | |
Jun 19 2007 | OPXA | Opexa Therapeutics ... | McWilliams David | Chief Executive Off ... | Option Exercise | A | 5.47 | 41,000 | 224,270 | 203,000 | |
Jun 19 2007 | OPXA | Opexa Therapeutics ... | Williams Jimmy Calvin | Chief Operating Off ... | Option Exercise | A | 5.47 | 30,000 | 164,100 | 97,875 | |
Jun 19 2007 | OPXA | Opexa Therapeutics ... | Hohlfeld Lynne | Chief Financial Off ... | Option Exercise | A | 5.47 | 32,000 | 175,040 | 67,000 | |
Feb 08 2007 | OPXA | Opexa Therapeutics ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 5.46 | 1,307 | 7,138 | 5,842,527 | 5.8 M to 5.8 M (-0.02 %) |
Jan 31 2007 | OPXA | Opexa Therapeutics ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 5.00 | 1,000 | 5,000 | 5,843,834 | 5.8 M to 5.8 M (-0.02 %) |
Jan 31 2007 | OPXA | Opexa Therapeutics ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 5.00 | 1,000 | 5,000 | 5,844,834 | 5.8 M to 5.8 M (-0.02 %) |
Jan 31 2007 | OPXA | Opexa Therapeutics ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Buy | P | 6.06 | 3,234 | 19,603 | 5,845,834 | 5.8 M to 5.8 M (+0.06 %) |
Jan 31 2007 | OPXA | Opexa Therapeutics ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Buy | P | 6.03 | 13,000 | 78,449 | 5,842,600 | 5.8 M to 5.8 M (+0.22 %) |
Jul 13 2006 | OPXA | Opexa Therapeutics ... | Hohlfeld Lynne | Chief Financial Off ... | Option Exercise | A | 8.25 | 12,500 | 103,125 | 35,000 | |
May 09 2006 | OPXA | Opexa Therapeutics ... | Frison Paul | Director | Option Exercise | A | 3.00 | 20,000 | 60,000 | 75,000 | |
May 09 2006 | OPXA | Opexa Therapeutics ... | Frison Paul | Director | Option Exercise | A | 3.00 | 15,000 | 45,000 | 55,000 | |
May 09 2006 | OPXA | Opexa Therapeutics ... | Frison Paul | Director | Option Exercise | A | 1.15 | 10,000 | 11,500 | 40,000 | |
May 09 2006 | OPXA | Opexa Therapeutics ... | Frison Paul | Director | Option Exercise | A | 1.15 | 30,000 | 34,500 | 30,000 | |
Apr 28 2006 | OPXA | Opexa Therapeutics ... | McWilliams David | CFO | Option Exercise | J | 2.00 | 1 | 2 | 6 | |
Apr 28 2006 | OPXA | Opexa Therapeutics ... | McWilliams David | CFO | Option Exercise | J | 2.00 | 2 | 4 | 7 | |
Apr 27 2006 | OPXA | Opexa Therapeutics ... | Rouse William | CFO | Option Exercise | J | 2.00 | 1 | 2 | 2 | |
Apr 26 2006 | OPXA | Opexa Therapeutics ... | Bailey Gregory | Director | Option Exercise | P | 0.50 | 1 | 1 | 2 | |
Jun 28 2006 | OPXA | Opexa Therapeutics ... | Magnetar Financial LLC | 10% Owner | Sell | S | 7.55 | 2,500 | 18,875 | 668,315 | 670.8 K to 668.3 K (-0.37 %) |
Jun 28 2006 | OPXA | Opexa Therapeutics ... | Magnetar Financial LLC | 10% Owner | Sell | S | 8.50 | 2,000 | 17,000 | 670,815 | 672.8 K to 670.8 K (-0.30 %) |
Jun 28 2006 | OPXA | Opexa Therapeutics ... | Magnetar Financial LLC | 10% Owner | Buy | P | 9.50 | 60 | 570 | 672,815 | 672.8 K to 672.8 K (+0.01 %) |
Jun 28 2006 | OPXA | Opexa Therapeutics ... | Magnetar Financial LLC | 10% Owner | Buy | P | 9.50 | 70 | 665 | 672,755 | 672.7 K to 672.8 K (+0.01 %) |
Jun 28 2006 | OPXA | Opexa Therapeutics ... | Magnetar Financial LLC | 10% Owner | Buy | P | 9.50 | 500 | 4,750 | 672,685 | 672.2 K to 672.7 K (+0.07 %) |
Jun 19 2006 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Option Exercise | A | 5.20 | 35,000 | 182,000 | 35,000 | |
Jun 19 2006 | OPXA | Opexa Therapeutics ... | Frison Paul | Director | Option Exercise | A | 5.20 | 2,500 | 13,000 | 10,000 | |
Jun 19 2006 | OPXA | Opexa Therapeutics ... | Hung David | Director | Option Exercise | A | 5.20 | 35,000 | 182,000 | 35,000 | |
Jun 19 2006 | OPXA | Opexa Therapeutics ... | Bailey Gregory | Director | Option Exercise | A | 5.20 | 35,000 | 182,000 | 35,000 | |
Jun 19 2006 | OPXA | Opexa Therapeutics ... | McWilliams David | CEO | Option Exercise | A | 5.00 | 120,000 | 600,000 | 162,000 | |
Jun 19 2006 | OPXA | Opexa Therapeutics ... | Rouse William | CFO | Option Exercise | A | 5.00 | 10,000 | 50,000 | 90,000 | |
Jun 19 2006 | OPXA | Opexa Therapeutics ... | Rouse William | CFO | Option Exercise | A | 5.00 | 65,000 | 325,000 | 80,000 | |
Mar 24 2006 | OPXA | Opexa Therapeutics ... | JARKESY GEORGE | 10% Owner | Option Exercise | J | 2.00 | 199,694 | 399,388 | 0 | |
Feb 06 2006 | OPXA | Opexa Therapeutics ... | JARKESY GEORGE | 10% Owner | Sell | D | 0.58 | 30,000 | 17,493 | 1,262,000 | 1.3 M to 1.3 M (-2.32 %) |
Feb 06 2006 | OPXA | Opexa Therapeutics ... | JARKESY GEORGE | 10% Owner | Sell | D | 0.60 | 6,000 | 3,600 | 1,292,000 | 1.3 M to 1.3 M (-0.46 %) |
Feb 06 2006 | OPXA | Opexa Therapeutics ... | JARKESY GEORGE | 10% Owner | Sell | D | 0.58 | 2,000 | 1,160 | 1,298,000 | 1.3 M to 1.3 M (-0.15 %) |
Dec 15 2005 | OPXA | Opexa Therapeutics ... | Rouse William | CFO | Buy | P | 0.65 | 1,500 | 975 | 164,420 | 162.9 K to 164.4 K (+0.92 %) |
Dec 15 2005 | OPXA | Opexa Therapeutics ... | McWilliams David | CEO | Buy | P | 0.63 | 2,000 | 1,260 | 66,256 | 64.3 K to 66.3 K (+3.11 %) |
Dec 06 2005 | OPXA | Opexa Therapeutics ... | Wesner Terry | Director | Option Exercise | A | 1.15 | 7,500 | 8,625 | 82,500 | |
Dec 06 2005 | OPXA | Opexa Therapeutics ... | Wesner Terry | Director | Option Exercise | A | 1.15 | 30,000 | 34,500 | 75,000 | |
Dec 06 2005 | OPXA | Opexa Therapeutics ... | Kamin Tony | Director | Option Exercise | A | 1.15 | 2,500 | 2,875 | 147,500 | |
Dec 06 2005 | OPXA | Opexa Therapeutics ... | Kamin Tony | Director | Option Exercise | A | 1.15 | 30,000 | 34,500 | 145,000 | |
Dec 06 2005 | OPXA | Opexa Therapeutics ... | Kamin Tony | Director | Buy | P | 0.69 | 5,000 | 3,450 | 105,000 | 100 K to 105 K (+5.00 %) |
Dec 06 2005 | OPXA | Opexa Therapeutics ... | Frison Paul | Director | Option Exercise | A | 1.15 | 10,000 | 11,500 | 75,000 | |
Dec 06 2005 | OPXA | Opexa Therapeutics ... | Frison Paul | Director | Option Exercise | A | 1.15 | 30,000 | 34,500 | 65,000 | |
Nov 02 2005 | OPXA | Opexa Therapeutics ... | JARKESY GEORGE | 10% Owner | Option Exercise | P | 4.00 | 159,753 | 639,012 | 439,325 | |
Nov 02 2005 | OPXA | Opexa Therapeutics ... | JARKESY GEORGE | 10% Owner | Option Exercise | P | 2.90 | 79,878 | 231,646 | 279,572 | |
Nov 02 2005 | OPXA | Opexa Therapeutics ... | JARKESY GEORGE | 10% Owner | Option Exercise | P | 2.00 | 199,694 | 399,388 | 199,694 | |
Nov 02 2005 | OPXA | Opexa Therapeutics ... | JARKESY GEORGE | 10% Owner | Gift | G | 0.00 | 71,667 | 0 | 395,755 | 324.1 K to 395.8 K (+22.11 %) |
Nov 02 2005 | OPXA | Opexa Therapeutics ... | JARKESY GEORGE | 10% Owner | Gift | G | 0.00 | 124,088 | 0 | 324,088 | 200 K to 324.1 K (+62.04 %) |
Nov 02 2005 | OPXA | Opexa Therapeutics ... | JARKESY GEORGE | 10% Owner | Gift | G | 0.00 | 200,000 | 0 | 200,000 | 0 to 200 K |
Oct 13 2005 | OPXA | Opexa Therapeutics ... | Lau Warren C | Sell | S | 2.00 | 36,000 | 72,000 | 1,062,748 | 1.1 M to 1.1 M (-3.28 %) | |
Oct 11 2005 | OPXA | Opexa Therapeutics ... | Kamin Tony | Director | Option Exercise | A | 3.00 | 15,000 | 45,000 | 115,000 | |
Oct 05 2005 | OPXA | Opexa Therapeutics ... | Frison Paul | Director | Option Exercise | A | 3.00 | 15,000 | 45,000 | 35,000 | |
Oct 05 2005 | OPXA | Opexa Therapeutics ... | McWilliams David | CEO | Option Exercise | P | 4.00 | 1 | 4 | 9 | |
Oct 05 2005 | OPXA | Opexa Therapeutics ... | McWilliams David | CEO | Option Exercise | P | 2.90 | 1 | 3 | 8 | |
Oct 05 2005 | OPXA | Opexa Therapeutics ... | McWilliams David | CEO | Option Exercise | P | 2.00 | 1 | 2 | 7 | |
Oct 05 2005 | OPXA | Opexa Therapeutics ... | McWilliams David | CEO | Option Exercise | J | 4.00 | 2 | 8 | 6 | |
Oct 05 2005 | OPXA | Opexa Therapeutics ... | McWilliams David | CEO | Option Exercise | J | 2.90 | 2 | 6 | 4 | |
Oct 05 2005 | OPXA | Opexa Therapeutics ... | McWilliams David | CEO | Option Exercise | J | 2.00 | 2 | 4 | 2 | |
Oct 05 2005 | OPXA | Opexa Therapeutics ... | McWilliams David | CEO | Option Exercise | J | 0.00 | 2 | 0 | 0 | |
Oct 05 2005 | OPXA | Opexa Therapeutics ... | McWilliams David | CEO | Option Exercise | J | 0.00 | 2 | 0 | 0 | |
Oct 05 2005 | OPXA | Opexa Therapeutics ... | McWilliams David | CEO | Buy | P | 0.00 | 23,334 | 0 | 64,256 | 40.9 K to 64.3 K (+57.02 %) |
Oct 05 2005 | OPXA | Opexa Therapeutics ... | McWilliams David | CEO | Buy | J | 0.00 | 36,922 | 0 | 40,922 | 4 K to 40.9 K (+923.05 %) |
Oct 05 2005 | OPXA | Opexa Therapeutics ... | Rouse William | CFO | Option Exercise | J | 4.00 | 1 | 4 | 3 | |
Oct 05 2005 | OPXA | Opexa Therapeutics ... | Rouse William | CFO | Option Exercise | J | 2.90 | 1 | 3 | 2 | |
Oct 05 2005 | OPXA | Opexa Therapeutics ... | Rouse William | CFO | Option Exercise | J | 2.00 | 1 | 2 | 1 | |
Oct 05 2005 | OPXA | Opexa Therapeutics ... | Rouse William | CFO | Option Exercise | J | 0.00 | 1 | 0 | 0 | |
Oct 05 2005 | OPXA | Opexa Therapeutics ... | Rouse William | CFO | Option Exercise | J | 0.00 | 1 | 0 | 0 | |
Oct 05 2005 | OPXA | Opexa Therapeutics ... | Rouse William | CFO | Buy | J | 0.00 | 11,670 | 0 | 162,920 | 151.3 K to 162.9 K (+7.72 %) |
May 12 2005 | OPXA | Opexa Therapeutics ... | JARKESY GEORGE | 10% Owner | Gift | G | 0.00 | 200,000 | 0 | 1,300,500 | 1.5 M to 1.3 M (-13.33 %) |
May 12 2005 | OPXA | Opexa Therapeutics ... | JARKESY GEORGE | 10% Owner | Sell | S | 7.00 | 2,000 | 14,000 | 1,500,500 | 1.5 M to 1.5 M (-0.13 %) |
May 12 2005 | OPXA | Opexa Therapeutics ... | JARKESY GEORGE | 10% Owner | Sell | S | 8.40 | 1,000 | 8,400 | 1,502,500 | 1.5 M to 1.5 M (-0.07 %) |
May 12 2005 | OPXA | Opexa Therapeutics ... | JARKESY GEORGE | 10% Owner | Sell | S | 8.32 | 1,000 | 8,316 | 1,503,500 | 1.5 M to 1.5 M (-0.07 %) |
May 12 2005 | OPXA | Opexa Therapeutics ... | JARKESY GEORGE | 10% Owner | Sell | S | 8.30 | 1,000 | 8,300 | 1,504,500 | 1.5 M to 1.5 M (-0.07 %) |
May 12 2005 | OPXA | Opexa Therapeutics ... | JARKESY GEORGE | 10% Owner | Sell | S | 7.59 | 2,000 | 15,180 | 1,505,500 | 1.5 M to 1.5 M (-0.13 %) |
May 12 2005 | OPXA | Opexa Therapeutics ... | JARKESY GEORGE | 10% Owner | Sell | S | 7.40 | 2,000 | 14,795 | 1,507,500 | 1.5 M to 1.5 M (-0.13 %) |
May 12 2005 | OPXA | Opexa Therapeutics ... | JARKESY GEORGE | 10% Owner | Sell | S | 6.84 | 1,000 | 6,840 | 1,509,500 | 1.5 M to 1.5 M (-0.07 %) |
May 12 2005 | OPXA | Opexa Therapeutics ... | JARKESY GEORGE | 10% Owner | Sell | S | 7.25 | 500 | 3,625 | 1,510,500 | 1.5 M to 1.5 M (-0.03 %) |
May 12 2005 | OPXA | Opexa Therapeutics ... | JARKESY GEORGE | 10% Owner | Sell | S | 7.50 | 1,000 | 7,500 | 1,511,000 | 1.5 M to 1.5 M (-0.07 %) |
May 12 2005 | OPXA | Opexa Therapeutics ... | JARKESY GEORGE | 10% Owner | Sell | S | 7.25 | 500 | 3,625 | 1,512,000 | 1.5 M to 1.5 M (-0.03 %) |
May 12 2005 | OPXA | Opexa Therapeutics ... | JARKESY GEORGE | 10% Owner | Buy | J | 14.00 | 1,012,500 | 14,175,000 | 1,512,500 | 500 K to 1.5 M (+202.50 %) |
Mar 31 2005 | OPXA | Opexa Therapeutics ... | McWilliams David | CEO | Option Exercise | P | 0.00 | 1 | 0 | 2 | |
Mar 31 2005 | OPXA | Opexa Therapeutics ... | McWilliams David | CEO | Option Exercise | P | 0.00 | 1 | 0 | 2 | |
Mar 31 2005 | OPXA | Opexa Therapeutics ... | McWilliams David | CEO | Option Exercise | A | 3.00 | 1 | 3 | 420,000 | |
Mar 31 2005 | OPXA | Opexa Therapeutics ... | McWilliams David | CEO | Buy | P | 0.00 | 1,500 | 0 | 4,000 | 2.5 K to 4 K (+60.00 %) |
Mar 30 2005 | OPXA | Opexa Therapeutics ... | Rouse William | CFO | Option Exercise | A | 3.00 | 1 | 3 | 2 | |
Mar 05 2004 | OPXA | Opexa Therapeutics ... | OTTESON JASON G | CEO and CFO | Buy | P | 0.00 | 12,500,000 | 12,500 | 16,090,994 | 3.6 M to 16.1 M (+348.09 %) |